Borosil Scientific Ltd restructures reporting, Sharad Tiwari ceases as senior personnel
Borosil Scientific Ltd announced that Mr. Sharad Tiwari ceased to be Senior Managerial Personnel effective July 14, 2026, due to a change in the internal reporting structure. He continues to be associated with the company. The disclosure was made under Regulation 30 of the SEBI (LODR) Regulations, 2015.
*this image is generated using AI for illustrative purposes only.
Borosil Scientific Ltd has announced a change in its senior management structure effective July 14, 2026, due to a reorganization of internal reporting protocols. Mr. Sharad Tiwari, who served as the Head of Sales for Domestic and International Pharmaceutical Primary Packaging, has ceased to be designated as a Senior Managerial Personnel. Despite this change in designation, the company confirmed that he continues to be associated with Borosil Scientific Ltd.
The disclosure was made to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing clarified that the cessation of Mr. Tiwari's status as Senior Managerial Personnel was strictly a result of the internal restructuring and did not involve a departure from the organization. He remains employed with the firm in a different capacity following the adjustment in the reporting hierarchy.
Role and Regulatory Compliance
Mr. Tiwari was responsible for overseeing sales operations across both domestic and international markets for the Pharmaceutical Primary Packaging division. The company emphasized that his continued association ensures stability in the division's operations despite the administrative reclassification. The notification was signed by Ramavtar Sharma, the Company Secretary & Compliance Officer, and submitted to BSE Limited and the National Stock Exchange of India Limited.
The filing detailed the specific regulatory provisions under which the information was disclosed, ensuring transparency regarding changes in key managerial personnel. The move aims to streamline the internal reporting structure within the organization.
Historical Stock Returns for BOROSCI
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.37% | -1.79% | -18.75% | +20.93% | -9.53% | 0.0% |
What specific operational efficiencies does Borosil Scientific aim to achieve through this restructuring of the reporting hierarchy?
How will Mr. Tiwari's new role impact the strategic direction of the Pharmaceutical Primary Packaging division?
Are further management restructuring plans expected within other divisions of the company following this change?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
